Novonesis (Novozymes) B carries a market capitalization of 115.36B, placing it among publicly traded companies globally.
| Market Cap | 115.36B |
| Enterprise Value | N/A |
Novonesis (Novozymes) B's stock has declined approximately -9.4459% over the past 52 weeks. The 50-day moving average sits at 386.75, while the 200-day moving average is 390.53.
| Beta (5Y) | N/A |
| 52-Week Price Change | -9.4459% |
| 50-Day Moving Average | 386.75 |
| 200-Day Moving Average | 390.53 |
| Average Volume (20 Days) | N/A |